Literature DB >> 29915060

Inflamed neutrophils sequestered at entrapped tumor cells via chemotactic confinement promote tumor cell extravasation.

Michelle B Chen1, Cynthia Hajal1, David C Benjamin2,3, Cathy Yu4, Hesham Azizgolshani1, Richard O Hynes2,3, Roger D Kamm5,4,6.   

Abstract

Systemic inflammation occurring around the course of tumor progression and treatment are often correlated with adverse oncological outcomes. As such, it is suspected that neutrophils, the first line of defense against infection, may play important roles in linking inflammation and metastatic seeding. To decipher the dynamic roles of inflamed neutrophils during hematogenous dissemination, we employ a multiplexed microfluidic model of the human microvasculature enabling physiologically relevant transport of circulating cells combined with real-time, high spatial resolution observation of heterotypic cell-cell interactions. LPS-stimulated neutrophils (PMNs) and tumor cells (TCs) form heterotypic aggregates under flow, and arrest due to both mechanical trapping and neutrophil-endothelial adhesions. Surprisingly, PMNs are not static following aggregation, but exhibit a confined migration pattern near TC-PMN clusters. We discover that PMNs are chemotactically confined by self-secreted IL-8 and tumor-derived CXCL-1, which are immobilized by the endothelial glycocalyx. This results in significant neutrophil sequestration with arrested tumor cells, leading to the spatial localization of neutrophil-derived IL-8, which also contributes to increasing the extravasation potential of adjacent tumor cells through modulation of the endothelial barrier. Strikingly similar migration patterns and extravasation behaviors were also observed in an in vivo zebrafish model upon PMN-tumor cell coinjection into the embryo vasculature. These insights into the temporal dynamics of intravascular tumor-PMN interactions elucidate the mechanisms through which inflamed neutrophils can exert proextravasation effects at the distant metastatic site.

Entities:  

Keywords:  cell migration; extravasation; inflammation; metastasis; neutrophils

Mesh:

Substances:

Year:  2018        PMID: 29915060      PMCID: PMC6142213          DOI: 10.1073/pnas.1715932115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Authors:  Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

2.  The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer.

Authors:  Jen-Kou Lin; Te-Cheng Yueh; Shih-Ching Chang; Chun-Chi Lin; Yuan-Tzu Lan; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  J Gastrointest Surg       Date:  2011-10-15       Impact factor: 3.452

3.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

4.  Elucidation of the Roles of Tumor Integrin β1 in the Extravasation Stage of the Metastasis Cascade.

Authors:  Michelle B Chen; John M Lamar; Ran Li; Richard O Hynes; Roger D Kamm
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

5.  Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development.

Authors:  Sung Jin Huh; Shile Liang; Arati Sharma; Cheng Dong; Gavin P Robertson
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

6.  On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics.

Authors:  Michelle B Chen; Jordan A Whisler; Julia Fröse; Cathy Yu; Yoojin Shin; Roger D Kamm
Journal:  Nat Protoc       Date:  2017-03-30       Impact factor: 13.491

7.  Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells.

Authors:  Jonathan D Spicer; Braedon McDonald; Jonathan J Cools-Lartigue; Simon C Chow; Betty Giannias; Paul Kubes; Lorenzo E Ferri
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

8.  Postoperative pneumonia after major lung resection.

Authors:  Olivier Schussler; Marco Alifano; Herve Dermine; Salvatore Strano; Anne Casetta; Sergio Sepulveda; Aziz Chafik; Sophie Coignard; Antoine Rabbat; Jean-François Regnard
Journal:  Am J Respir Crit Care Med       Date:  2006-02-10       Impact factor: 21.405

9.  Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients.

Authors:  Hany Noh; Minseob Eomm; Airi Han
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

Review 10.  Distinct Functions of Neutrophil in Cancer and Its Regulation.

Authors:  Zvi Granot; Jadwiga Jablonska
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

View more
  55 in total

Review 1.  Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.

Authors:  Vardhman Kumar; Shyni Varghese
Journal:  Adv Healthc Mater       Date:  2018-12-05       Impact factor: 9.933

2.  YAP Enhances Tumor Cell Dissemination by Promoting Intravascular Motility and Reentry into Systemic Circulation.

Authors:  David C Benjamin; Joon Ho Kang; Bashar Hamza; Emily M King; John M Lamar; Scott R Manalis; Richard O Hynes
Journal:  Cancer Res       Date:  2020-06-26       Impact factor: 12.701

Review 3.  Neutrophil plasticity in the tumor microenvironment.

Authors:  Morgan A Giese; Laurel E Hind; Anna Huttenlocher
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 4.  The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.

Authors:  Mark F Coughlin; Roger D Kamm
Journal:  Adv Healthc Mater       Date:  2020-01-29       Impact factor: 9.933

5.  Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier Microvasculature.

Authors:  Sharon Wei Ling Lee; Marco Campisi; Tatsuya Osaki; Luca Possenti; Clara Mattu; Giulia Adriani; Roger Dale Kamm; Valeria Chiono
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

Review 6.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

Review 7.  Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.

Authors:  Laura Keller; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2019-08-27       Impact factor: 60.716

Review 8.  Actin dynamics during tumor cell dissemination.

Authors:  Chandrani Mondal; Julie S Di Martino; Jose Javier Bravo-Cordero
Journal:  Int Rev Cell Mol Biol       Date:  2020-11-24       Impact factor: 6.813

9.  Engineering new microvascular networks on-chip: ingredients, assembly, and best practices.

Authors:  James J Tronolone; Abhishek Jain
Journal:  Adv Funct Mater       Date:  2021-01-20       Impact factor: 18.808

10.  The effects of luminal and trans-endothelial fluid flows on the extravasation and tissue invasion of tumor cells in a 3D in vitro microvascular platform.

Authors:  Cynthia Hajal; Lina Ibrahim; Jean Carlos Serrano; Giovanni S Offeddu; Roger D Kamm
Journal:  Biomaterials       Date:  2020-10-19       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.